Global Bio-Pharma R&D

Assisted in a $750 million global bio-pharma acquisition with Corporate HQ in the Midwest and the European HQ in the UK.  Built an infrastructure organization from the ground up, establishing a global WAN and supporting infrastructure services.  Lead the effort in building a US Data Center in 63 days while negotiating hosting services for the UK operation, resulting in exiting a Transition Services Agreement (TSA) 10 months early and saving the organization $25 million.

Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut.